Evanston Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-91,141
Closed -$3.58M 70
2017
Q4
$3.58M Buy
91,141
+22
+0% +$837 0.86% 38
2017
Q3
$3.36M Buy
91,119
+164
+0.2% +$5.84K 0.81% 41
2017
Q2
$3.5M Buy
90,955
+128
+0.1% +$4.69K 0.86% 38
2017
Q1
$3.09M Buy
90,827
+9,490
+12% +$312K 0.84% 40
2016
Q4
$2.67M Sell
81,337
-5,744
-7% -$186K 0.82% 45
2016
Q3
$2.81M Sell
87,081
-1,182
-1% -$38.3K 0.88% 43
2016
Q2
$2.73M Buy
88,263
+1,212
+1% +$37.9K 0.89% 41
2016
Q1
$2.61M Buy
87,051
+1,141
+1% +$31.5K 0.86% 44
2015
Q4
$2.38M Buy
85,910
+8,141
+10% +$232K 0.83% 43
2015
Q3
$2.37M Buy
77,769
+2,830
+4% +$98.5K 0.79% 46
2015
Q2
$2.75M Buy
+74,939
New +$2.67M 0.9% 38

Other funds holding EHC

Evanston Advisors's EHC Position: Q1 2018 in Review

Evanston Advisors sold out of Encompass Health (EHC) in Q1 2018, closing a stake of 91,141 shares — an estimated $3.58M sold.

Evanston Advisors first reported a position in EHC in Q2 2015 and held it in 11 quarters. The position peaked at $3.58M in Q4 2017. 354 funds tracked by Wall St. Rank hold EHC as of Q1 2018.

  • Evanston Advisors reported no remaining Encompass Health position as of Q1 2018 after selling out during the quarter.
  • Evanston Advisors sold 91,141 Encompass Health shares in Q1 2018, an estimated $3.58M.
  • Evanston Advisors first reported a position in Encompass Health in Q2 2015 and held it in 11 quarters.
  • Evanston Advisors's Encompass Health position peaked at $3.58M in Q4 2017.
  • 354 funds tracked by Wall St. Rank held Encompass Health as of Q1 2018.

Based on Evanston Advisors's 13F filing for Q1 2018, filed 9 May 2018.